Paragon 28, Inc.

  • Market Cap: Micro Cap
  • Industry: Medical Specialties
  • ISIN: US69913P1057
USD
13.09
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

0

Shareholding (Dec 2024)

FII

3.48%

Held by 63 FIIs

DII

67.96%

Held by 23 DIIs

Promoter

12.41%

How big is Paragon 28, Inc.?

22-Jun-2025

As of Apr 22, Paragon 28, Inc. has a market capitalization of 1,097.73 million, with net sales of 256.19 million and a net profit of -54.64 million for the latest four quarters ending in December 2024. The company has shareholder's funds of 130.59 million and total assets of 290.72 million as of December 2024.

Market Cap: As of Apr 22, Paragon 28, Inc. has a market capitalization of 1,097.73 million, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters ending in December 2024, Paragon 28, Inc. reported net sales of 256.19 million and a net profit of -54.64 million.<BR><BR>Balance Sheet Snapshot: As of December 2024, the company has shareholder's funds amounting to 130.59 million and total assets of 290.72 million.

Read More

What does Paragon 28, Inc. do?

22-Jun-2025

Paragon 28, Inc. is a micro-cap company in the Medical Specialties industry, reporting net sales of $72 million and a net profit loss of $11 million as of December 2024. Key metrics include a market cap of $1.1 billion, a debt-to-equity ratio of 0.59, and a return on equity of -41.25%.

Overview:<BR>Paragon 28, Inc. operates in the Medical Specialties industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 72 Million (Quarterly Results - Dec 2024) <BR>Most recent Net Profit: -11 Million (Quarterly Results - Dec 2024) <BR>Market cap: USD 1,097.73 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 99.31% <BR>Debt Equity: 0.59 <BR>Return on Equity: -41.25% <BR>Price to Book: 8.41<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Medical Specialties

stock-summary
Market cap

USD 1,098 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

99.31%

stock-summary
Debt Equity

0.59

stock-summary
Return on Equity

-41.25%

stock-summary
Price to Book

8.41

Revenue and Profits:
Net Sales:
72 Million
(Quarterly Results - Dec 2024)
Net Profit:
-11 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.98%
0%
11.98%
6 Months
141.96%
0%
141.96%
1 Year
33.71%
0%
33.71%
2 Years
-28.63%
0%
-28.63%
3 Years
-29.09%
0%
-29.09%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Paragon 28, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
20.21%
EBIT Growth (5y)
-221.26%
EBIT to Interest (avg)
-6.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.59
Sales to Capital Employed (avg)
0.88
Tax Ratio
2.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
71.90%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.41
EV to EBIT
-28.80
EV to EBITDA
-52.83
EV to Capital Employed
5.67
EV to Sales
4.58
PEG Ratio
NA
Dividend Yield
99.31%
ROCE (Latest)
-19.67%
ROE (Latest)
-41.25%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Bearish
Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 41 Schemes (15.73%)

Foreign Institutions

Held by 63 Foreign Institutions (3.48%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 18.32% vs 17.67% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 62.12% vs 24.48% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "71.70",
          "val2": "60.60",
          "chgp": "18.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.50",
          "val2": "-14.60",
          "chgp": "89.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "2.00",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "-4.10",
          "chgp": "87.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.10",
          "val2": "-29.30",
          "chgp": "62.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-89.70%",
          "val2": "-323.40%",
          "chgp": "23.37%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.39% vs 19.29% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.04% vs 14.56% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "256.20",
          "val2": "216.40",
          "chgp": "18.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-22.20",
          "val2": "-30.10",
          "chgp": "26.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.30",
          "val2": "5.20",
          "chgp": "155.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-4.80",
          "chgp": "83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-54.60",
          "val2": "-57.50",
          "chgp": "5.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-159.20%",
          "val2": "-211.00%",
          "chgp": "5.18%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
71.70
60.60
18.32%
Operating Profit (PBDIT) excl Other Income
-1.50
-14.60
89.73%
Interest
3.00
2.00
50.00%
Exceptional Items
-0.50
-4.10
87.80%
Consolidate Net Profit
-11.10
-29.30
62.12%
Operating Profit Margin (Excl OI)
-89.70%
-323.40%
23.37%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 18.32% vs 17.67% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 62.12% vs 24.48% in Dec 2023

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
256.20
216.40
18.39%
Operating Profit (PBDIT) excl Other Income
-22.20
-30.10
26.25%
Interest
13.30
5.20
155.77%
Exceptional Items
-0.80
-4.80
83.33%
Consolidate Net Profit
-54.60
-57.50
5.04%
Operating Profit Margin (Excl OI)
-159.20%
-211.00%
5.18%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 18.39% vs 19.29% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 5.04% vs 14.56% in Dec 2023

stock-summaryCompany CV
About Paragon 28, Inc. stock-summary
stock-summary
Paragon 28, Inc.
Medical Specialties
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available